Lapas attēli
PDF
ePub
[merged small][merged small][merged small][merged small][subsumed][merged small][merged small][merged small][merged small][ocr errors][ocr errors][merged small][merged small][merged small][merged small][merged small]

the fast blue salt B test which involves the fast blue salt B reagent which gives various colors with the phenolic cannabinoids, and the Grlic test which involves the use of hydrogen peroxide and sulfuric acid.84,85

It should be emphasized that it is difficult to say whether or not a sample being tested contains active psychotomimetic substances through the use of most of these chemical tests and false-positive reactions are not uncommon.

(2) microscopic tests-Cannabis sativa plants bear numerous hairs of two types that are useful in the identification of this plant, if it is in the powdered or crushed form-i.e., as one would find in a marihuana cigarette. The first of these types of hairs is known as a cystolith since it contains a crystal of calicum carbonate in the basal portion of the hair (see Figure 3). If a mineral acid is added to a microscopic preparation of a suspected sample of marihuana and the calcium carbonate crystal in the basal portion of the hair decomposes with effervescence (carbon dioxide), this is good evidence for the presence of marihuana in the sample. Until just recently, it was thought that the unicellular cystoliths of C. sativa were unique to this species and therefore offered a positive means of identification. However, a recent comprehensive study of hundreds of species of plants has revealed that similar cystoliths occur in many others."

On the other hand, most of the literature fails to point out that in addition to the presence of unicellular cystoliths on C. sativa plants, there are also characteristic resin-producing multicellular grandular hairs (see

CH

XV cannabipinol

[ocr errors]

Figure 3). Observation of both types of hairs in a single sample of suspected marihuana is positive evidence that C. sativa is present in the sample.

A precaution on the use of the microscopic method for identifying marihuana samples is that the method is of no value if the sample contains hashish, which of course would not contain any appreciable amounts of cellular elements for identification.

(3) thin-layer chromatography–The technic of thin-layer chromatography of a petroleum ether extract from a suspected Cannabis sativa-containing sample offers a rapid, simple, inexpensive and accurate assessment of the specific cannabinoid content of the sample, both from a qualitative as well as from a semi-quantitative point

of view. Following a rapid development of the sample on Kieselgel G plates impregnated with N,N-dimethylformamide and using cyclohexane as the eluent, the various cannabinoids can be separated into well-defined spots. Subsequent treatment of the chromatogram with fast blue salt B reagent results in the production of several colors for the separated components. Tetrahydrocannabinol under these conditions forms a scarlet color, cannabinol is violet, cannabidiol and cannabidiol carboxylic acid are orange, cannabichromene is brownish-violet and cannabicyclol is brick red. The R, values of the separated components offer additional evidence for their identification.30 The technic offers the simplest, most accurate and most practical means for the identification of marihuana samples.

(4) gas chromatography-A final method for the identification of C. sativa samples is to examine extracts from them by means of gas chromatography. Several studies37-41 have been reported recently using this technic, and it appears to be useful. However, the instrument is expensive, the technic requires some degree of skill for its operation and maintenance and reference samples are a necessity. summary

(1) Cannabis sativa plants grown in temperate zones-and especially in the northern part of the United States-have not been shown to contain appreciable amounts of tetrahydrocannabinols or any other psychotomimetic principles.

(2) The long-established opinion that male Cannabis sativa plants are devoid of psychotomimetic substances is incorrect.

[blocks in formation]
[ocr errors][merged small][merged small][merged small][ocr errors][merged small][merged small][ocr errors][merged small][merged small][merged small][merged small][merged small][ocr errors][merged small][ocr errors][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small]

prior to 1967 must be considered of questionable value. variability of cannabinoids

Although exhaustive and definitive studies have not been reported, it is generally recognized that Cannabis sativa plants grown in temperate zones or areas with short light days produce lower concentrations of resin than plants grown in tropical or subtropical zones. There is a fair amount of evidence that the resin from the former plants is higher in cannabidiolic acid and cannabidiol with little, if any, tetrahydrocannabinols. Plants from the latter areas, on the other hand, have little cannabidiolic acid, and larger amounts of the tetra

X

OH

cannabidiol

hydrocannabinols, 4.30

To point out the importance and significance of this information, it has been shown that the constituents of Cannabis sativa change on standing, and that these changes are more rapid in tropical areas than in temperate zones. Cannabidiolic acid, an inactive psychotomimetic substance, is transformed into the inactive cannabidiol which is then converted to the active tetrahydrocannabinols, and then into the inactive cannabinol (see Figure 2). It can be seen that almost any batch of Cannabis sativa can have a quite variable chemical composition, depending on the geography of the source material, the age of the plant when harvested, the age

of the harvested sample and the storage conditions, as well as other factors.30

While the tetrahydrocannabinols are generally claimed to be the active psychotomimetic principles of marihuana, they do not necessarily have to be present in the dried plant material or resin in order for a person to experience psychotomimetic effects when smoking this sample. Proof of this has recently been advanced by Claussen and Korte who have clegantly shown that precursors such as tetrahydrocannabinol carboxylic acid readily decarboxylate during the smoking process to form the active tetra hydrocannabinols. Cannabidiolic acid and cannabidiol are not cyclized to the active tetrahydrocannabinols during smoking. Also, the heat labile double bond in the tetrahydrocannabinols is only very slowly isomerized during the smoking process. About 98 percent of the cannabinoids present in marihuana are destroyed by the smoking process,31

identification of marihuana

There are several methods that have been used for the detection of Cannabis sativa in cigarettes or when admixed with other plant materials. They are-

(1) chemical tests-Several cheinical tests have been developed for the identification of C. sativa. Perhaps the most widely used of these is the Beam test, which simply involves extraction of the suspected sample with petroleum ether, evaporation of the solvent and the addition of a few drops of alcoholic potassium hydroxide to the residue. The production of a violet color is taken as evidence that the sample contains marihuana. The reaction is a test for the presence of the inactive cannabidiol and cannabidiolic acid and other constituents of C. sativa do not give a positive test, including the tetrahydrocannabinols. A number of plants other than C. sativa will give false-positive reactions to this test but it is claimed that these can be eliminated for the most part by shaking the violet color reac tion mixture of a positive test with chloroform and allowing the chloroform and water layers to separate. If the reaction is a false-positive one, the violet color will not migrate into the chloroform layer 32.33

Other tests that have been applied are the Ghamravy test which involves the use of dimethylamino benzalde hyde and sulfuric acid; the Duquenois-Negm test which involves vanillin, acetaldehyde and ethanol; the modified Duquenois-Negm test which involves hydrochloric acid followed by extraction with chloroform;

[graphic][subsumed][subsumed][merged small][subsumed]

Diagrammatic sketch of typical hairs of Cannabis sativa as viewed under the microscope (C) cystolith hair; (G) glandular hair; (E) leaf epidermis.

(3) Two common constituents of Cannabis sativa-i.e., cannabidiolic acid and cannabichromene-are sedative principles. The assessment of any effect of the constituents on the body during the smoking of marihuana cigarettes has not been established.

(4) Chemical tests for detecting marihuana are unreliable and they do not establish the presence of C. sativa psychotomimetic principles. Falsepositive reactions also can be expected with the tests. A trained microscopist can identify C. sativa in crushed or powdered marihuana samples by detecting the cystolith unicellular, nonglandular hairs in addition to typical multicellular glandular hairs. This method cannot be used if hashish is the type of marihuana present. The best means for identifying C. sativa in suspected marihuana samples is by thin-layer chromatography.

(5) A total of 15 cannabinoid constituents of C. sativa have been isolated in pure form and their structures determined. Eight of these have not been tested for psychotomimetic activity.

(6) The most important psychotomimetic agent in C. sativa is (-)-A1transtetrahydrocannabinol but the

(-)-A1(6) -transtetrahydrocannabinol isomer, also active, is present in a much lower concentration.

(7) A good animal assay for detecting the psychotomimetic acavity of C. sativa is lacking and this has hindered research in this area.

[blocks in formation]

necessarily mean that we will soon know whether or not marihuana smoking can be considered a safe practice.

(9) In light of our present day knowledge, legalization of marihuana under government control and distribution does not appear to be a realistic possibility. There is adequate and overwhelming data available that marihuana samples-even those from plants grown in the same geographic area-are so variable in their chemical composition that standardization of the drug would be next to impossible. One must remember that not only must the active psychotomimetic tetrahydrocannabinols be taken into consideration as active principles but the opposite acting sedative principles cannabidiolic acid and cannabichromene cannot be discounted as contributing to the overall activity. Chemical standardization of each batch of marihuana could be carried out with little difficulty but adjustment of the biological potency of high or low psychotomimetic activity drug would be next to impossible. On this ground alone, a standard marihuana activity preparation could not be made available for general use.

There are no clear-cut and simple answers to the marihuana controversy, and based on the direction in which current research is headed, the situation will become worse before it becomes better.

One can expect that the Pandora's box of marihuana will remain closed for some time to come.

references

1. McGlothlin, W.H., "Hallucinogenic Drugs: A Perspective With Special Reference to

Peyote and Cannabis," Rand Corporation.
Santa Monica, California (1964)

2. Quimby, M.W, and N.J. Doorenbos, school of pharmacy, University of Mississippi, University, Mississippi (1969)

3. Farnsworth, N.R., "Hallucinogenic Plants," Science, 162, 1086 (1968)

4. Mechoulam, R., and Y. Gaoni, "Recent Advances in the Chemistry of Hashish, Fortschr. Chem. Org. Naturst., 25, 175 (1967)

5. Gaoni, Y., and R. Mechoulam, "Isolation, Structure and Partial Synthesis of an Active Constituent of Hashish," J Am. Chem. Soc, 86, 1646 (1964)

6. Isbell, H., C.W. Gorodetzsky. D. Jasinski, U. Claussen, Fv. Spulak, and F. Korte, "Effects of (-)-A-transtetrahydrocannabinol in man," "Psychopharmacologia, 11, 184 (1967)

7. Weil, A.T., NE. Zinberg, and J.M. Nelsen, Clinical and Psychological Effects of Manhuana in Man, Science, 162, 1234 (1968) 8. Scheckel, C.L., E Boff, P. Dahlen, and T Smart, Behavioral Effects in Monkeys of Racemates of Two Biologically Active Manbuana Constituents, Science, 160, 1467 (1968)

9. Hively, R.L, WA Mosher, and F.W. Hoffmann, "Isolation of Trans-A-tetrahydrocannabinol From Marihuana, J Am. Chem. Soc, 88, 1832(1966)

10. Korte, F., M. Hagg, and U. Claussen, "Tetrahydrocannabinol-Carboxylic Acid, a Component of Hashish (1)," Angew. Chem., 77, 862(1965)

11. Spulak, F.v, U. Claussen, H.W. Fehlhaber, and F. Korte, "Haschisch-XIX. Cannabidiokarbonsaure tetrahydrocannabitriol EsEin Neuer Haschisch-Inhaltsstoff," Tetrahedron, 24, 5379(1968)

ter.

12. Adams, R., DC. Pease, and J. Clark, "Isolation of Cannabinol, Cannabidiol and Quebrachitol from Red Oil of Minnesota Wild Hemp," J Am. Chem. Soc., 62, 2194 (1940)

13. Adams, R., D.C. Pease, J.H. Clark, and B.R. Baker, "Structure of Cannabinol. I. Preparation of an Isomer, 3-hydroxy-1-n-amyl6,6,9-trimethyl-6-dibenzopyran," J. Am. Chem. Soc., 62, 2197 (1940)

14. Mechoulam, R., and Y Gaoni, "Hashish-IV. The Isolation and Structure of Cannibinolic, Cannabidiolic and Cannabigerolic Acids," Tetrahedron, 21, 1223 (1965)

15. Guoni, Y., and R. Mechoulam, The Structure and Synthesis of Cannabigerol, a New Hashish Constituent, Proc. Chem. Soc., 1964, 82(1964)

16. Yamauchi, T. Y. Shoy ama, Y. Matsuo, and I Nishioka, "Cannabis 111 Cannabigerol Monomethyl Ether, a New Component of Hemp," Chem. Pharm. Bull, Tokyo, 16, 1164 (1968)

17. Kabelik, J., Z. Krejci, and F. Santavy, "Cannabis as a Medicament," Bull. Narcotics, 12, No. 3, 5(1960)

18. Schultz, O.E., and G. Haffner, "Zur Kenntnis Eines Sedativen und Antibakteriellen Wirkstoffes aus dem Deutschen Fasethanf (Cannabis sativa)," Z. Naturforsch., 14B, 98 (1959)

19. Schultz, O.E., and G. Haffner, Zur Kenntnis eines Sedativen Wirkstoffes aus Deutschen Faserhanf (Cannabis sativa). 1." Arch. Pharm., 291, 391(1958)

20. Adams, R., M. Hunt, and JH Clark, "Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp 1.," J. Am. Chem. Soc., 62, 196(1940)

21. Mechoulam, R., and Y Shvo, "Hashish.

I.

The Structure of Cannabidiol," Tetrahedron, 19, 2073 (1963)

22. Vollner, L. D. Bieniek, and F., Korte, "Haschisch XX. Cannabidivarin, ein neuer Haschisch-Inhaltsstoff," Tetrahedron Letters, 1969, 145 (1969)

23 Claussen, U., F.v. Spulak, and F. Korte, "Zur Chemische Klassifizierung von Pflanzen-XXXI. Haschisch-X. Cannabichromen, ein neuer Haschisch-Inhaltsstoff," hedron, 22, 1477 (1966)

Tetra

24. Gaoni, Y., and R. Mechoulam, "Cannabichromene, a New Active Principle in Hashish," Chem. Commun., 1966, 20

(1966)

25. Shovama, Y., T. Toshio, T Yamauchi, and 1. Nishioka, "Cannabis. II. Cannabichro

'cannabis sativa'

(continued from page 414)

menic Acid, a Genuine Substance of Cannabichromene," Chem. Pharm. Bull., Tokyo, 16, 1157(1968)

26. Claussen, U., F.v. Spulak, and F. Korte, "Haschisch-XIV. Zur Kenntnis der Inhaltsstoffe des Haschisch," Tetrahedron, 24, 1021 (1967) 27. Jacob, A., and A.R. Todd, "Cannabidiol and Cannabol, Constituents of Cannabis indica Resin," Nature, 145, 350(1940) 28. Covello, M., "Richerche Chimiche e Farmacologiche Sulla Cannable indica Coltivata in Italia. II. Degradazione dell' attivita biologica delle droga in rapporto all'inbecchiamento • separazione chromatografica delle frazioni attive dagli estratti alcoolico ed etereo," Il Farmaco, Sci. Tec., 3, 8 (1948)

29. Mechoulam, R, and Y. Gaoni, "Hashish. X. The Absolute Configuration of A1-tetrahydrocannabinol, the Major Active Constit

uent of Hashish,"

1967, 1109(1967)

Tetrahedron

Letters, 30. Grlic, L., "Recent Advances in the Chemical Research of Cannabis," Bull. Narcotics, 16(4), 29(1964)

31. Claussen, U., and F. Korte, "Haschisch. XV. Über das Verhalten von Hanf und von A-6a, 10a-trans-tetrahydrocannabinol Beim Rauchen," Ann. Chem. Liebigs, 713, 162 (1968) 32. Mechoulam, R., Z. Ben-Zvi, and Y. Gaoni, "Hashish. XIII. On the Nature of the Beam Test, Tetrahedrom, 24, 5615(1988) 33. Nickolls, L.C., "Note on Beam's Test for Hashish, (Indian hemp)," Analyst, 61, 604 (1936)

34. Grlic, L., "A Comparative Study on Some Chemical and Biological Characteristics of Various Samples of Cannabis Resin," Bull, Narcotica, 14(3), 37(1962)

35. Schultz, O.E., "Der Gegenwartige Stand der Cannabis-Forschung," Planta Med., 18, 371

(1964)

36. Nakamura, G.R., "Forensic Aspects of Cystolith Hairs of Cannabis and Other Plants,"

J. Assoc. Ofic. Anal. Chem., 52, 5(1969) 37. Farmilo, C.G., and T.W.M. Davis, Paper and Gas Chromatographic Analysis of Cannabis," J. Pharm. Pharmacol., 13, 767 (1961)

38. Claussen, U., W. Borger, and F. Korte. "Zat Planzen Chemischen Klassifizierung von XXVII (Haschisch, VI). Gaschromatographische Analyse der Inhaltsstoffe des Hanfes," Ann. Chem. Liebigs, 693, 158 (1966)

39. Caddy, B., F. Fish, and W.D.C. Wilson, "Gas Chromatography of Indian Hemp (Cannabis sativa L.)," J. Pharm. PharInacol., 19, 851 (1967)

40. Heaysman, L.T., E.A. Walker, and D.T. Lewis, "The Application of Gas Chromatog raphy to the Examination of the Constituents of Cannabis sativa L.,” Analyst, 92, 450(1967)

41. Davis, T.W.M., C.G. Farmilo, and M Osadchuk, "Identification and Origin Determination of Cannabis by Gas and Paper Chromatography," Anal. Chem., 35, 751 (1963)

Mr. ROGERS. Thank you very much, Dr. Apple. It is a very interesting statement, and I am glad to see that you make certain recommendations on how you feel the law should be changed.

I presume your criticisms pretty much apply to the Senate bill as well.

Dr. APPLE. Yes, Mr. Chairman. It is the same basic provisions in the Senate bill to which we objected when we testified there, and I might point out further, we brought our objections to these provisions to the attention of the Justice Department even when they were in draft stage.

Mr. ROGERS. And no reaction?

Dr. APPLE. I feel, Mr. Chairman, that all our pleas fell on deaf

ears.

Mr. ROGERS. Have you discussed it with HEW?

Dr. APPLE. No, because the jurisdiction is now in the hands of the Justice Department. Our major concern is the tremendous amount of paperwork that is going to be created which we believe will not serve any useful purpose whatsoever.

Mr. ROGERS. Thank you.

Mr. Preyer?

Mr. PREYER. Thank you, Mr. Chairman.

I gather the way the bill is presently drafted in the Senate bill, you would oppose it. You make a number of suggestions of changes of definitions. These are technical matters, and I am not prepared to pass on all of those at this time, but it seems to me that many of those are changes which fall within the spirit of the Senate bill. That is, I am sure it is not their intention under that bill to put a $25,000 fine on pharmacists through mere inadvertence, and some of the other dangers which you foresee, I don't think it is the intent of that bill to bring them about. Therefore, with a little creative draftsmanship we might be able to get around those problems, and meet your objections.

Then you also suggest two changes to the bill, one, the banning of mail-order pharmacy operations. You say 17 States prohibit that

now.

Dr. APPLE. That is right, sir.

Mr. PREYER. So you would have a Federal ban on this type of operation throughout the country?

Dr. APPLE. Mr. Preyer, we feel that this legislation is designed, and intended to stop the illicit traffic of these dangerous substances. Yet, it is quite possible, and illicit mail traffic goes on all the time. We are aware of it and we have reported it in numerous instances to the authorities. At the State level, they are almost without recourse. A person in one State can send in a piece of paper to a mail-order house in another State and obtain 500 or 5,000 units of these drugs. The mail order operator has no knowledge of the parties, whether it is an authentic prescription, whether the physician has the right to prescribe all this goes on, and we seem oblivious to this whole problem.

We have pointed this out time and time again in congressional testimony in the last few years, and in discussions with HEW and Justice.

« iepriekšējāTurpināt »